| Conferences \ Circulating Biomarkers World Congress 2016 \ Circulating DNA, Circulating RNA, Circulating Tumor Cells, Circulating Proteins \ Agenda \ Jason Baum |
| Register | Login |
The Use of Circulating Protein Biomarkers to Identify Mechanisms of Resistance and Restore Sensitivity: The Example of the Bispecific Antibody MM-141 (Istiratumab)Tuesday, 22 March 2016 at 16:00  Add to Calendar ▼2016-03-22 16:00:002016-03-22 17:00:00Europe/LondonThe Use of Circulating Protein Biomarkers to Identify Mechanisms of Resistance and Restore Sensitivity: The Example of the Bispecific Antibody MM-141 (Istiratumab)SELECTBIOenquiries@selectbiosciences.comUnderstanding why certain patients are insensitive to standard therapies represents a key unmet medical need. By identifying markers of chemo-resistance, we can then look to restore sensitivity using targeted therapies. MM-141 (istiratumab), an investigational bispecific antibody, co-targets IGF-1R and ErbB3; the co-development of a diagnostic test to detect a circulating protein biomarker will be discussed. |
Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonCirculating DNA, Circulating RNA, Circulating Tumor Cells, Circulating ProteinsSELECTBIOenquiries@selectbiosciences.com
